Literature DB >> 8913265

Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cells.

N Sheibani1, W A Frazier.   

Abstract

Thrombospondin-1 (TSI) is a modular extracellular matrix glycoprotein and expressed by many cell types in culture. Thrombospondin-1 inhibits angiogenesis and its expression inversely correlates with the degree of invasiveness and metastasis in tumor cell lines. Here, we demonstrate that expression of Polyoma middle T oncogene in NIH3T3 cells results not only in transformation but also represses expression of three thrombospondin isoforms, TS1, TS2, and TS3. Similar results were observed in ras, and to a lesser extent in src transformed NIH3T3 cells. Middle T and ras transformed cells expressed higher levels of c-jun mRNA, while the src transformed cells expressed higher levels of junB mRNA when compared to control cells. Thus, repression of thrombospondin levels appears to play an important role in establishment and maintenance of a malignant phenotype. This is mediated, at least in part, by alteration in c-jun activity in middle T and ras transformed NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913265     DOI: 10.1016/0304-3835(96)04341-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

Review 1.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 2.  The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors:  G Gasparini
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

3.  In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.

Authors:  S Filleur; O V Volpert; A Degeorges; C Voland; F Reiher; P Clézardin; N Bouck; F Cabon
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

4.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

5.  E2F-1 directly regulates thrombospondin 1 expression.

Authors:  Wei Ji; Wei Zhang; Wuhan Xiao
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.